Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Switchback Systems is developing a proprietary, highly scalable benchtop DNA synthesis and gene assembly platform designed to dramatically reduce the time, cost, and waste associated with synthetic nucleic acid production. The system aims to democratize access to high-quality synthetic DNA for scientists across multiple industries by providing an on-demand, deployable solution that bypasses traditional service models. No clinical results are reported as this is a research tools/platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Switchback Systems.